skip to main |
skip to sidebar
Breast cancer drug with fewer side effects found to cut risk of tumors
"Exemestane, sold under the brand name Aromasin, can reduce the risk of tumors by 65% among post-menopausal women prone to develop breast cancer, researchers say. It's already used to treat breast cancer and does not appear to have the potentially lethal side effects of tamoxifen or raloxifene."
No comments:
Post a Comment